Vertex’s effort to provide fertility support services to those on government insurance programs who want to take the ...

Crizanlizumab (Adakveo) failed to outperform placebo in patients with sickle cell disease, the phase III STAND trial showed ... Emmaus Medical, and Vertex Pharmaceuticals. Co-authors also reported ...

Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy ... based therapy will be an option for SCD patients aged 12 years and over who have ...

Traditional stem cell transplants can cure sickle cell disease but come with serious risks and require a suitable ...

Sebastien Beauzile is the first person in New York to be cured of sickle cell anemia due to a genetic treatment called Lyfgenia.

Vertex Pharmaceuticals continues to see patients with sickle cell disease start the process to receive its Casgevy therapy, ...

Oluwatosin Adesoye finds much that pleases her as she notes her evolution over two years as a columnist for Sickle Cell ...

HHS had argued that Vertex's plan to cover fertility services for some patients that took its gene therapy would violate anti-kickback and inducement laws.

The Department of Health - Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, has announced the ...

Gene therapy, which promises a possible cure for rare diseases like sickle cell, is losing early investors to higher-reward ...

Columnist Oluwatosin Adesoye had to let go of certain goals and dreams due to sickle cell disease, but she's found a new ...